n(1)-methylnicotinamide has been researched along with Cirrhosis in 1 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, W | 1 |
| Rong, G | 1 |
| Gu, J | 1 |
| Fan, C | 1 |
| Guo, T | 1 |
| Jiang, T | 1 |
| Deng, W | 1 |
| Xie, J | 1 |
| Su, Z | 1 |
| Yu, Q | 1 |
| Mai, J | 1 |
| Zheng, R | 1 |
| Chen, X | 1 |
| Tang, X | 1 |
| Zhang, J | 1 |
1 other study available for n(1)-methylnicotinamide and Cirrhosis
| Article | Year |
|---|---|
Nicotinamide N-methyltransferase ameliorates renal fibrosis by its metabolite 1-methylnicotinamide inhibiting the TGF-β1/Smad3 pathway.
Topics: Animals; Cells, Cultured; Fibrosis; Kidney; Male; Mice; Mice, Inbred C57BL; Niacinamide; Nicotinamid | 2022 |